Home
Biomarin Pharmaceutical BMRN spent $470K on lobbying in Q4 2023 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $470,000
- Quarter
- Q4 2023
- Client
- Biomarin Pharmaceutical
- Reported
- 24/01/22
Up 113.6% from last quarter
What else happened in Biomarin Pharmaceutical around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Biomarin Pharmaceutical's other lobbying reports
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$340K
$340K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$30K
$30K
Reported 07/06
for Q2 2017
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$530K
$530K
Reported 04/20
for Q1
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 04/20
for Q1